Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Radium-223 Inhibits Osseous Prostate Cancer Growth by Dual Targeting of Cancer Cells and Bone Microenvironment in Mouse Models.

Suominen MI, Fagerlund KM, Rissanen JP, Konkol YM, Morko JP, Peng Z, Alhoniemi EJ, Laine SK, Corey E, Mumberg D, Ziegelbauer K, Käkönen SM, Halleen JM, Vessella RL, Scholz A.

Clin Cancer Res. 2017 Aug 1;23(15):4335-4346. doi: 10.1158/1078-0432.CCR-16-2955. Epub 2017 Mar 31.

2.

In vitro model of bone to facilitate measurement of adhesion forces and super-resolution imaging of osteoclasts.

Deguchi T, Alanne MH, Fazeli E, Fagerlund KM, Pennanen P, Lehenkari P, Hänninen PE, Peltonen J, Näreoja T.

Sci Rep. 2016 Mar 3;6:22585. doi: 10.1038/srep22585.

3.

Survival benefit with radium-223 dichloride in a mouse model of breast cancer bone metastasis.

Suominen MI, Rissanen JP, Käkönen R, Fagerlund KM, Alhoniemi E, Mumberg D, Ziegelbauer K, Halleen JM, Käkönen SM, Scholz A.

J Natl Cancer Inst. 2013 Jun 19;105(12):908-16. doi: 10.1093/jnci/djt116. Epub 2013 May 16.

PMID:
23682134
4.

Specificity and clinical performance of two commercial TRACP 5b immunoassays.

Ylipahkala H, Fagerlund KM, Janckila AJ, Houston B, Laurie D, Halleen JM.

Clin Lab. 2009;55(5-6):223-8.

PMID:
19728556
5.

Effects of a low-frequency sound wave therapy programme on functional capacity, blood circulation and bone metabolism in frail old men and women.

Zheng A, Sakari R, Cheng SM, Hietikko A, Moilanen P, Timonen J, Fagerlund KM, Kärkkäinen M, Alèn M, Cheng S.

Clin Rehabil. 2009 Oct;23(10):897-908. doi: 10.1177/0269215509337273. Epub 2009 Aug 28.

PMID:
19717506
6.

Clinical performance of six different serum tartrate-resistant acid phosphatase assays for monitoring alendronate treatment.

Fagerlund KM, Janckila AJ, Ylipahkala H, Tiitinen SL, Nenonen A, Cheng S, Uusi-Rasi K, Yam LT, Väänänen HK, Halleen JM.

Clin Lab. 2008;54(9-10):347-54.

PMID:
19097492
7.

Improved methods for testing antiresorptive compounds in human osteoclast cultures.

Rissanen JP, Ylipahkala H, Fagerlund KM, Long C, Väänänen HK, Halleen JM.

J Bone Miner Metab. 2009;27(1):105-9. doi: 10.1007/s00774-008-0002-1. Epub 2008 Nov 19.

PMID:
19018457
8.

Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption.

Halleen JM, Tiitinen SL, Ylipahkala H, Fagerlund KM, Väänänen HK.

Clin Lab. 2006;52(9-10):499-509. Review.

PMID:
17078477
9.

Effects of proteolysis and reduction on phosphatase and ROS-generating activity of human tartrate-resistant acid phosphatase.

Fagerlund KM, Ylipahkala H, Tiitinen SL, Janckila AJ, Hamilton S, Mäentausta O, Väänänen HK, Halleen JM.

Arch Biochem Biophys. 2006 May 15;449(1-2):1-7. Epub 2006 Mar 27.

PMID:
16620768

Supplemental Content

Loading ...
Support Center